Colgate-Palmolive Company $CL Shares Sold by Dai ichi Life Insurance Company Ltd

Dai ichi Life Insurance Company Ltd lowered its holdings in Colgate-Palmolive Company (NYSE:CL) by 5.7% during the first quarter, Holdings Channel reports. The fund owned 192,622 shares of the company’s stock after selling 11,566 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Colgate-Palmolive were worth $16,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. Kemnay Advisory Services Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth about $25,000. CBIZ Investment Advisory Services LLC lifted its holdings in shares of Colgate-Palmolive by 86.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after buying an additional 150 shares during the period. TD Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 61.4% in the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after buying an additional 124 shares during the period. Triumph Capital Management boosted its stake in shares of Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after buying an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $26,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $90.74 on Friday. The stock has a market capitalization of $72.61 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 4.74 and a beta of 0.33. The stock has a 50-day moving average of $90.77 and a 200 day moving average of $88.96. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company earned $0.91 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 82.49%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CL shares. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a research report on Tuesday, April 21st. TD Cowen restated a “hold” rating and issued a $85.00 price objective on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Bank of America dropped their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $99.00 target price on shares of Colgate-Palmolive in a research note on Monday, May 4th. Finally, UBS Group increased their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Twelve analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $97.82.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.